Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Vicarious Surgical shares are trading lower by 20% during Tuesday's session. The company announced a 1-for-30 reverse stock split. 3 Summer "Power Patterns" Are About to Trigger (One With 90% Win Rate ...

RBOT is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RBOT shares has decreased $0.11 since the market last closed. This is a 3.90 ...

Vicarious Surgical's Beta 2 system is complete, it's now working toward its next system, v1.0. In order to reduce cash burn, RBOT cut its workforce by 14 percent while cutting other costs. With the ...

Total Operating Expenses: $15.7 million, a 2% decrease from $16.1 million in Q1 2024. R&D Expenses: $9.4 million, down from $10 million in Q1 2024. General and Administrative Expenses: $5.3 million, ...

Vicarious Surgical Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (RBOT.WS) Revenue EPS ...

Vicarious Surgical Inc. (RBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

Earlier this year, the San Diego Padres’ superstar shortstop Fernando Tatis Jr. had to leave a game after suffering from obvious pain. At the time, the Padres put Tatis on the 10-day injured list, ...